ArticleOncology letters2013

microRNA-199a is able to reverse cisplatin resistance in human ovarian cancer cells through the inhibition of mammalian target of rapamycin.

Zhongxian Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.